Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry.

Mateusz Sokolski,Sander Trenson,Justyna M Sokolska,Domenico D'Amario,Philippe Meyer,Nana K Poku,Tor Biering-Sørensen,Mats C Højbjerg Lassen,Kristoffer G Skaarup,Eduardo Barge-Caballero,Anne-Catherine Pouleur,Davide Stolfo,Gianfranco Sinagra,Klemens Ablasser,Viktoria Muster,Peter P Rainer,Markus Wallner,Alessandra Chiodini,Pascal S Heiniger,Fran Mikulicic,Judith Schwaiger,Stephan Winnik,Huseyin A Cakmak,Margherita Gaudenzi,Massimo Mapelli,Irene Mattavelli,Matthias Paul,Irina Cabac-Pogorevici,Claire Bouleti, Marzia Lilliu, Chiara Minoia,Jeroen Dauw,Jérôme Costa,Ahmet Celik,Nathan Mewton, Carlos E L Montenegro,Yuya Matsue,Goran Loncar,Michal Marchel,Aris Bechlioulis,Lampros Michalis,Marcus Dörr,Edgard Prihadi,Felix Schoenrath,Daniel R Messroghli,Wilfried Mullens,Lars H Lund,Giuseppe M C Rosano,Piotr Ponikowski,Frank Ruschitzka,Andreas J Flammer

ESC heart failure（2021）

引用 24|浏览30

暂无评分

摘要

Hospitalized COVID-19 patients with HF are at increased risk for in-hospital death. In-hospital worsening of HF or acute HF de novo are common and associated with a further increase in in-hospital mortality.

查看译文

关键词

COVID-19,Cardiovascular disease,Heart failure,Risk factors,SARS-CoV2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要